FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028338273> ?p ?o ?g. }

• W2028338273 endingPage "114" @default.
• W2028338273 startingPage "103" @default.
• W2028338273 abstract "Our institutional experience with 68 pediatric patients undergoing cardiac transplantation was reviewed to determine the impact of unconventional donor and recipient management protocols implemented to extend the availability of this therapy. The introduction of donor blood insulin cardioplegia was associated with a significant improvement in patient and graft survival. Among 63 ABO-matched transplant procedures, both the patient and graft loss rate were significantly lower (by multivariable analysis) with the use of the donor blood insulin cardioplegia versus conventional cardioplegia, despite significantly longer ischemic times in the former group. Twenty-three (33.8%) patients were deemed at ultra-high risk: eight of 11 patients with cardiomyopathy transplanted following ECMO support survived without major sequelae; three of four additional patients survived early retransplantation. Ten patients underwent intentional ABO-incompatible transplantation under a protocol of plasma exchange on bypass. There were two early deaths because of nonspecific graft failure and respiratory complications with mild vascular rejection, and one late death because of lymphoma. Among seven surviving ABO-incompatible patients followed up to 31 months, there have been no episodes of humoral rejection despite development of antidonor blood group antibodies in A to O, but not B to O, mismatches. The results with pediatric cardiac transplantation continue to improve as a result of changes in both surgical and medical protocols permitting salvage of patients conventionally considered at high risk or nontransplantable. Our institutional experience with 68 pediatric patients undergoing cardiac transplantation was reviewed to determine the impact of unconventional donor and recipient management protocols implemented to extend the availability of this therapy. The introduction of donor blood insulin cardioplegia was associated with a significant improvement in patient and graft survival. Among 63 ABO-matched transplant procedures, both the patient and graft loss rate were significantly lower (by multivariable analysis) with the use of the donor blood insulin cardioplegia versus conventional cardioplegia, despite significantly longer ischemic times in the former group. Twenty-three (33.8%) patients were deemed at ultra-high risk: eight of 11 patients with cardiomyopathy transplanted following ECMO support survived without major sequelae; three of four additional patients survived early retransplantation. Ten patients underwent intentional ABO-incompatible transplantation under a protocol of plasma exchange on bypass. There were two early deaths because of nonspecific graft failure and respiratory complications with mild vascular rejection, and one late death because of lymphoma. Among seven surviving ABO-incompatible patients followed up to 31 months, there have been no episodes of humoral rejection despite development of antidonor blood group antibodies in A to O, but not B to O, mismatches. The results with pediatric cardiac transplantation continue to improve as a result of changes in both surgical and medical protocols permitting salvage of patients conventionally considered at high risk or nontransplantable." @default.
• W2028338273 created "2016-06-24" @default.
• W2028338273 creator A5002551259 @default.
• W2028338273 creator A5028562399 @default.
• W2028338273 date "2001-01-01" @default.
• W2028338273 modified "2023-10-16" @default.
• W2028338273 title "Pediatric Heart Transplantation: Improving Results in High-Risk Patients" @default.
• W2028338273 cites W1530583566 @default.
• W2028338273 cites W1572009433 @default.
• W2028338273 cites W1954313480 @default.
• W2028338273 cites W1975566386 @default.
• W2028338273 cites W2012065442 @default.
• W2028338273 cites W2013273435 @default.
• W2028338273 cites W2014024741 @default.
• W2028338273 cites W2015326385 @default.
• W2028338273 cites W2034142395 @default.
• W2028338273 cites W2043395027 @default.
• W2028338273 cites W2048121649 @default.
• W2028338273 cites W2052690651 @default.
• W2028338273 cites W2071079074 @default.
• W2028338273 cites W2072386632 @default.
• W2028338273 cites W2077321849 @default.
• W2028338273 cites W2107750788 @default.
• W2028338273 cites W2108409970 @default.
• W2028338273 cites W2158610924 @default.
• W2028338273 cites W2171240745 @default.
• W2028338273 cites W2171404980 @default.
• W2028338273 cites W4293312603 @default.
• W2028338273 cites W63608106 @default.
• W2028338273 doi "https://doi.org/10.1053/pcsu.2001.23729" @default.
• W2028338273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11460979" @default.
• W2028338273 hasPublicationYear "2001" @default.
• W2028338273 type Work @default.
• W2028338273 sameAs 2028338273 @default.
• W2028338273 citedByCount "4" @default.
• W2028338273 crossrefType "journal-article" @default.
• W2028338273 hasAuthorship W2028338273A5002551259 @default.
• W2028338273 hasAuthorship W2028338273A5028562399 @default.
• W2028338273 hasConcept C126322002 @default.
• W2028338273 hasConcept C141071460 @default.
• W2028338273 hasConcept C176080213 @default.
• W2028338273 hasConcept C2778789114 @default.
• W2028338273 hasConcept C2778849806 @default.
• W2028338273 hasConcept C2911091166 @default.
• W2028338273 hasConcept C71924100 @default.
• W2028338273 hasConceptScore W2028338273C126322002 @default.
• W2028338273 hasConceptScore W2028338273C141071460 @default.
• W2028338273 hasConceptScore W2028338273C176080213 @default.
• W2028338273 hasConceptScore W2028338273C2778789114 @default.
• W2028338273 hasConceptScore W2028338273C2778849806 @default.
• W2028338273 hasConceptScore W2028338273C2911091166 @default.
• W2028338273 hasConceptScore W2028338273C71924100 @default.
• W2028338273 hasIssue "1" @default.
• W2028338273 hasLocation W20283382731 @default.
• W2028338273 hasLocation W20283382732 @default.
• W2028338273 hasOpenAccess W2028338273 @default.
• W2028338273 hasPrimaryLocation W20283382731 @default.
• W2028338273 hasRelatedWork W1987453322 @default.
• W2028338273 hasRelatedWork W2003938723 @default.
• W2028338273 hasRelatedWork W2019221809 @default.
• W2028338273 hasRelatedWork W2047967234 @default.
• W2028338273 hasRelatedWork W2118496982 @default.
• W2028338273 hasRelatedWork W2125614435 @default.
• W2028338273 hasRelatedWork W2134892892 @default.
• W2028338273 hasRelatedWork W2439875401 @default.
• W2028338273 hasRelatedWork W2737177965 @default.
• W2028338273 hasRelatedWork W3035841175 @default.
• W2028338273 hasVolume "4" @default.
• W2028338273 isParatext "false" @default.
• W2028338273 isRetracted "false" @default.
• W2028338273 magId "2028338273" @default.
• W2028338273 workType "article" @default.